LIBRELEASE (CHLORDIAZEPOXIDE) — FDA Approval NDA017813 (VALEANT PHARM INTL)
LIBRELEASE (CHLORDIAZEPOXIDE) — FDA Approval NDA017813 (VALEANT PHARM INTL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LIBRELEASE; Active ingredients: CHLORDIAZEPOXIDE; Application number: NDA017813.
| Brand name | LIBRELEASE |
|---|---|
| Active ingredients | CHLORDIAZEPOXIDE |
| Application number | NDA017813 |
| Sponsor | VALEANT PHARM INTL |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19830912 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →